Key Findings: This article provides a discussion of a discussion of diverse gastrointestinal (GI) disorders, including the emergence of cannabis hyperemesis syndrome, and the available therapeutic strategies to manage symptoms and improve quality of life.
Type of Study: Meta-analysis
Study Result: Inconclusive
Research Location(s): United States
Year of Pub: 2024
Cannabinoids Studied: Cannabinoid (unspecified)
Phytocannabinoid Source: Not Applicable
Citation: McFee RB. Gastrointestinal disorders - Clinical challenges for the primary care clinician. Dis Mon. 2024 Dec;70(12):101828. doi: 10.1016/j.disamonth.2024.101828. Epub 2024 Dec 3. PMID: 39627098.